Marin Kollef

Critical Care and Intensive Care Medicine · 2000–2021

A researcher in the Science corpus: 14 papers; trusts 3 researchers and is trusted by 13 researchers here, as inferred from the citation graph.

Subfields

Critical Care and Intensive Care Medicine — 42 citations into it; #8 of 82 by trust here, #14 by citations
Molecular Medicine — 22 citations into it
Pulmonary and Respiratory Medicine — 21 citations into it

Whom Marin Kollef trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts Marin Kollef overall

Papers from Marin Kollef's perspective

Ordered by how strongly the researchers Marin Kollef trusts endorse each paper. Same corpus, a different order for every researcher.

Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. (Chest)
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (Critical Care Medicine)
Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. (American Journal of Medicine)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. (Clinical Infectious Diseases)
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis* (Critical Care Medicine)
Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014 (Journal of the American Medical Association (JAMA))
Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. (American Journal of Respiratory and Critical Care Medicine)
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. (European Respiratory Journal)
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. (Journal of Infectious Diseases)

Their papers

The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections (2012) — 863 citations
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update (2021) — 613 citations
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. (2020) — 779 citations
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia (2017) — 1,180 citations
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. (2012) — 548 citations
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality (2005) — 1,330 citations
Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. (2005) — 1,008 citations
Ventilator-Associated Pneumonia (2005) — 599 citations
Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center* (2003) — 607 citations
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. (2003) — 628 citations
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. (2002) — 1,321 citations
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. (2002) — 976 citations
Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. (2000) — 653 citations
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. (2000) — 1,857 citations